Company Overview - Tongling Jieya Biotechnology Co., Ltd. was established in 1999, specializing in the research, production, and sales of wet wipes, with over 20 years of industry experience [1] - The company was listed on the Shenzhen Stock Exchange's Growth Enterprise Market on December 3, 2021, and is steadily advancing its fundraising projects [1] - In Q1 2025, the company reported a revenue of 124 million yuan and a net profit of 1,006.27 thousand yuan [1] U.S. Factory Development - The U.S. wet wipes factory is currently under construction and is expected to commence production next year [2] - To manage higher labor costs in the U.S., the factory will implement automated production lines and optimize management processes to enhance operational efficiency and cost structure [2] - Key investment risks for the U.S. factory include uncertainties in facility renovation and approval processes, customer audit outcomes, potential delays in production start, and cultural differences affecting production efficiency [2] Customer Relations and Market Strategy - The company primarily relies on forecast orders from clients, which are mostly well-known global enterprises, ensuring stable cooperation [3] - The company is focused on optimizing its business structure and enhancing core competitiveness through technological innovation [3] - The Shanghai R&D center is dedicated to independent research and development of cosmetic formulations and collaboration with domestic and international clients [3] Business Performance and Future Outlook - Since Q2 2025, the wet wipes business has seen a stable order flow, with existing clients maintaining orders and new business opportunities in Europe and Canada [4] - The company is actively expanding its market presence with international brand clients [4] - Future business drivers include expanding product categories and sales regions based on existing brand clients and leveraging the U.S. factory [4] Financial Management - The company has approximately 600 million yuan of idle fundraising capital allocated for principal-protected financial products, ensuring the safety of investments while supporting ongoing projects [4] - The company adheres to regulatory guidelines to prevent the disclosure of undisclosed significant information during investor communications [4]
洁雅股份(301108) - 2025年7月30日 投资者关系活动记录表